The Commission has reported to the European Parliament and the Council of the EU on the international treatment of central banks and public entities managing public debt with regard to OTC derivatives transactions. The report analyses the treatment of central banks and debt management offices within the legal frameworks of a significant number of non-EU countries. The report envisages exempting certain non-EU countries’ central banks and public debt management offices from the scope of the Regulation on OTC derivatives, central counterparties and trade repositories (EMIR). It will be updated regularly as the reform process advances in the countries where the legislation is not yet final, as well as in other G20 jurisdictions not yet included in the report. (Source: Commission Reports on OTC Derivatives Treatment)